Concourse Financial Group Securities’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-119
Closed -$80.9K 6500
2024
Q4
$80.9K Buy
119
+64
+116% +$43.5K ﹤0.01% 1012
2024
Q3
$57.8K Buy
55
+9
+20% +$9.46K ﹤0.01% 1127
2024
Q2
$48.3K Buy
46
+6
+15% +$6.31K ﹤0.01% 1184
2024
Q1
$38.5K Buy
40
+12
+43% +$11.6K ﹤0.01% 1297
2023
Q4
$24.6K Buy
28
+7
+33% +$6.15K ﹤0.01% 1420
2023
Q3
$17.3K Sell
21
-1
-5% -$823 ﹤0.01% 1486
2023
Q2
$15.8K Buy
22
+5
+29% +$3.59K ﹤0.01% 1520
2023
Q1
$14K Hold
17
﹤0.01% 1568
2022
Q4
$12.3K Buy
17
+5
+42% +$3.61K ﹤0.01% 1585
2022
Q3
$8K Buy
12
+11
+1,100% +$7.33K ﹤0.01% 1547
2022
Q2
$1K Sell
1
-5
-83% -$5K ﹤0.01% 2131
2022
Q1
$4K Sell
6
-279
-98% -$186K ﹤0.01% 1909
2021
Q4
$180K Buy
285
+3
+1% +$1.9K 0.01% 771
2021
Q3
$171K Buy
282
+36
+15% +$21.8K 0.01% 770
2021
Q2
$137K Sell
246
-6
-2% -$3.34K 0.01% 853
2021
Q1
$119K Buy
252
+168
+200% +$79.3K 0.01% 860
2020
Q4
$41K Sell
84
-124
-60% -$60.5K ﹤0.01% 1209
2020
Q3
$116K Buy
208
+147
+241% +$82K 0.01% 732
2020
Q2
$38K Buy
61
+6
+11% +$3.74K ﹤0.01% 1076
2020
Q1
$27K Sell
55
-10
-15% -$4.91K ﹤0.01% 1126
2019
Q4
$24K Buy
+65
New +$24K ﹤0.01% 1204
2019
Q3
Sell
-75
Closed -$23K 4759
2019
Q2
$23K Sell
75
-94
-56% -$28.8K ﹤0.01% 1200
2019
Q1
$69K Buy
169
+96
+132% +$39.2K 0.01% 771
2018
Q4
$27K Buy
+73
New +$27K ﹤0.01% 1021
2018
Q3
Hold
0
4478